Charles Schwab’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103M Buy
281,403
+1,060
+0.4% +$398K 0.01% 784
2026
Q1
$78.8M Buy
280,343
+2,749
+1% +$798K 0.01% 861
2025
Q4
$82.2M Sell
277,594
-2,503
-0.9% -$754K 0.01% 828
2025
Q3
$68.9M Buy
280,097
+16,493
+6% +$3.33M 0.01% 939
2025
Q2
$41.1M Sell
263,604
-18,417
-7% -$1.96M 0.01% 1223
2025
Q1
$22.2M Sell
282,021
-50,368
-15% -$5.34M ﹤0.01% 1585
2024
Q4
$30.7M Sell
332,389
-47,090
-12% -$3.68M 0.01% 1444
2024
Q3
$19.4M Sell
379,479
-47,058
-11% -$2.43M ﹤0.01% 1707
2024
Q2
$24.4M Buy
+426,537
New +$21.5M ﹤0.01% 1543

Other funds holding CLS

Charles Schwab's CLS Position: Q2 2026 in Review

Charles Schwab increased its Celestica (CLS) stake by 0.38% in Q2 2026, buying an estimated $398K and bringing the position to 281,403 shares worth $103M. The position accounts for 0.01% of the portfolio, ranked #784.

Charles Schwab first reported a position in CLS in Q2 2024 and has held it in 9 quarters since. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Charles Schwab held 281,403 shares of Celestica worth $103M as of Q2 2026.
  • Charles Schwab bought 1,060 Celestica shares in Q2 2026, an estimated $398K.
  • Celestica made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #784 holding.
  • Charles Schwab first reported a position in Celestica in Q2 2024 and has held it in 9 quarters since.
  • 873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.